Tauriga Sciences, Inc. Approved to Continue Trading on OTCQB Marketplace
July 30 2014 - 8:01AM
Tauriga Sciences, Inc. (OTCQB:TAUG) ("Tauriga" or the "Company"), a
diversified life sciences company, today announced it received
notice of approval effective as of July 29, 2014 from OTC Markets
Group, Inc. ("OTC Markets") to continue trading on the OTCQB
Marketplace. The notice confirms that Tauriga submitted all
the mandatory documents and has successfully met all the initial
requirements for the OTCQB.
The OTCQB Marketplace helps investors easily identify OTC-traded
companies that report to the Securities and Exchange Commission,
and it has replaced OTC Bulletin Board as the standard designation
for the vast majority of this category of OTC
Companies. Recently, OTC Markets has established new
eligibility standards for companies to be able to trade on the
OTCQB Marketplace. These new standards are aimed at improving
information available to investors. Companies that do not comply
with the new procedures within the required timeframe will be
downgraded to OTC Pink.
Tauriga Chief Executive Officer Dr. Stella Sung commented, "We
are pleased that the OTC Markets approved our application to
continue trading on the transparent and respected OTCQB
Marketplace. The Company is working diligently to build strong
business fundamentals and is both proud to be trading on the OTCQB
and hopeful of graduating to a senior exchange such as NASDAQ at a
future date."
About Tauriga Sciences, Inc.:
Tauriga Sciences, Inc. (TAUG) is a diversified life sciences
company focused on generating profitable revenues through license
agreements and the development of a proprietary technology platform
in the nano-robotics space. The mission of the Company is to
acquire and build a diversified portfolio of cutting edge
technology assets that is capital efficient and of significant
value to the shareholders. The Company's business model includes
the acquisition of licenses, equity stakes, rights on both an
exclusive and non-exclusive basis, and entire businesses.
Management is firmly committed to building lasting shareholder
value in the short, intermediate, and long terms. On July 10, 2014,
Tauriga acquired a California based topical cannabis lotion
company. Please visit the Company's corporate website at
www.tauriga.com.
NON SOLICITATION:
This press release does not constitute an offer to sell or the
solicitation of an offer to buy any of these securities, nor will
there be any sale of these securities in any state or other
jurisdiction in which such offer, solicitation or sale is not
permitted. Any securities offered or issued in connection with the
above-referenced merger and/or investment have not been registered,
and will be offered pursuant to an exemption from registration.
DISCLAIMER:
Forward-Looking Statements: Except for statements of historical
fact, this news release contains certain "forward-looking
statements" as defined by the Private Securities Litigation Reform
Act of 1995, including, without limitation expectations, beliefs,
plans and objectives regarding the development, use and
marketability of products. Such forward-looking statements are
based on present circumstances and on TAUG's predictions with
respect to events that have not occurred, that may not occur, or
that may occur with different consequences and timing than those
now assumed or anticipated. Such forward-looking statements involve
known and unknown risks, uncertainties and other factors, and are
not guarantees of future performance or results and involve risks
and uncertainties that could cause actual events or results to
differ materially from the events or results expressed or implied
by such forward-looking statements. Such factors include general
economic and business conditions, the ability to successfully
develop and market products, consumer and business consumption
habits, the ability to fund operations and other factors over which
TAUG has little or no control. Such forward-looking statements are
made only as of the date of this release, and TAUG assumes no
obligation to update forward-looking statements to reflect
subsequent events or circumstances. Readers should not place undue
reliance on these forward-looking statements. Risks, uncertainties
and other factors are discussed in documents filed from time to
time by TAUG with the Securities and Exchange Commission. This
press release does not and shall not constitute an offer to sell or
the solicitation of any offer to buy any of the securities, nor
shall there be any sale of the securities, in any state or
jurisdiction in which such offer, solicitation or sale would be
unlawful prior to registration or qualification under the
securities laws of any such state. The securities have not been
registered under the Securities Act of 1933, as amended (the
"Securities Act") or any state securities laws, and may not be
offered or sold in the United States absent registration, or an
applicable exemption from registration, under the Securities Act
and applicable state securities laws.
CONTACT: Tauriga Sciences, Inc.:
Dr. Stella M. Sung,
Chairman and Chief Executive Officer
Tauriga Sciences, Inc.
www.tauriga.com
San Diego: + 1-858-353-5749
Montreal: + 1-514-840-3697
Email: ssung@tauriga.com
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From Apr 2024 to May 2024
Tauriga Sciences (CE) (USOTC:TAUG)
Historical Stock Chart
From May 2023 to May 2024